Alpha Tau Medical DRTSW
NASDAQ DRTSW
$4.24 +0.39 (+10.13%)
As of: Aug 21, 2026 · 3:59 PM EDT

Alpha Tau Medical (DRTSW) Cash from Investing Activities (2021 - 2022)

Alpha Tau Medical (DRTSW) posted Cash from Investing Activities of -$92.4 million for Q2 2022, down 30898.99% sequentially from -$298000.0 in Q1 2022.

Alpha Tau Medical (DRTSW) Cash from Investing Activities (2021 - 2022) Analysis & Trends

Alpha Tau Medical has reported Cash from Investing Activities for 2 years, with the latest figure at -$92.4 million in Q2 2022.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Investing Activities (Qtr)
1 Vertex Pharmaceuticals 139.13 Bn 131.28 Bn 2.84 Bn -45.80 Mn
2 Regeneron Pharmaceuticals 85.77 Bn 77.77 Bn 3.93 Bn -92.70 Mn
3 Argenx Se 64.64 Bn 59.46 Bn 1.37 Bn -
4 Moderna 58.29 Bn 53.16 Bn 52.00 Mn 329.00 Mn
5 BeOne Medicines 41.92 Bn 36.82 Bn 1.53 Bn -49.35 Mn
6 Alnylam Pharmaceuticals 31.58 Bn 28.28 Bn 992.69 Mn -363.46 Mn
7 BioNTech SE 28.12 Bn 9.73 Bn 668.28 Mn -3.17 Bn
8 Insmed 27.39 Bn 26.22 Bn 358.27 Mn 24.51 Mn
9 Royalty Pharma 27.27 Bn 26.43 Bn - -229.72 Mn
10 Alpha Tau Medical 383.00 Mn 200.58 Mn - -

Historic Data

Download Data
DateValue
Jun 30, 2022 -92.38 Mn
Jun 30, 2022 -92.38 Mn
Mar 31, 2022 -298,000.00
Mar 31, 2022 -298,000.00
Mar 31, 2021 -609,000.00
Mar 31, 2021 -609,000.00